Skip to content

Elizabeth E. Slonena

4 papers in the library · 128 citations · publishing 2014-2021

Papers

Sort Most recent Most cited

Effects of a Brief Mindful Hypnosis Intervention on Stress Reactivity: A Randomized Active Control Study.

International Journal of Clinical and Experimental Hypnosis 2021 Elizabeth E. Slonena, Gary R Elkins

A novel, audio-based brief mindful hypnosis (BMH) intervention for reducing stress-reactivity during the Trier Social Stress Test (TSST) was investigated. Fifty-five college-aged participants with elevated stress were randomized to BMH or a cognitive training (CT) active-control condition. Participants received a BMH or CT session and downloaded the audio-recorded intervention for daily home...

DOI: 10.1080/00207144.2021.1952845 (opens in new tab) Full text (opens in new tab) Meditation Mindful hypnosis Randomized controlled trial Relaxation +1

Are 24-hour motor activity patterns associated with continued rapid response to ketamine?

Neuropsychiatric Disease and Treatment October 1, 2018 Wallace C. Duncan, Elizabeth E. Slonena, Nadia S. Hejazi et al. 17 citations

PURPOSE: This study examined the links between 24-hour activity patterns (specifically, amplitude and timing of wrist activity) and the persisting qualities of clinical antidepressant response to the glutamatergic modulator ketamine. METHODS: Twenty-four-hour activity patterns were compared across 5 days of 24-hour activity rhythms in patients with major depressive disorder who displayed either...

Motor-Activity Markers of Circadian Timekeeping Are Related to Ketamine's Rapid Antidepressant Properties.

Biological Psychiatry September 1, 2017 Wallace C. Duncan, Elizabeth E. Slonena, Nadia S. Hejazi et al.

The rapid clinical antidepressant effects of the glutamatergic modulator ketamine may be due to its ability to restore synaptic plasticity and related effects on sleep-wake and circadian systems. Preclinical studies indicate that ketamine alters expression of circadian clock-associated molecules, and clinical studies of ketamine on plasticity-related biomarkers further suggest an association...

Effect of Baseline Anxious Depression on Initial and Sustained Antidepressant Response to Ketamine

The Journal of Clinical Psychiatry September 25, 2014 Dawn F. Ionescu, David A. Luckenbaugh, Mark J. Niciu et al. 111 citations

OBJECTIVE: Patients with anxious depression are typically more difficult to treat with monoaminergic antidepressants compared to those with nonanxious depression. Although novel research has shown that the N-methyl-D-aspartate (NMDA) receptor antagonist ketamine has rapidly acting, relatively sustained effects in treating depression, we predicted that, consistent with the existent literature on...